What is COST's health score?

COSTCO WHOLESALE CORP /NEW (COST) has a TradeApes health score of 70 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is COST's estimated fair value?

Based on our 5-year discounted cash flow model, COSTCO WHOLESALE CORP /NEW's estimated fair value is $295.61 per share, representing a -69.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is COST undervalued or overvalued?

Our model currently rates COST as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for COST... Refresh in a moment for the full analysis.

COSTCO WHOLESALE CORP /NEW (COST)

Consumer Cyclical Overvalued medium healthy

$961.83

Updated: 2026-06-03

TradeApes Score

Financial Strength

85 Strong

Operating Trend

78 Strong

Relative Value

50 Mixed

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $295.61

DCF Upside -69.3%

Sector Rank #2647 of 3184

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.